Shareholders that lost money on Harmony Biosciences Holdings, Inc. (HRMY) should contact Levi & Korsinsky about Securities Fraud Investigation - HRMY
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Harmony Biosciences Holdings, Inc. (HRMY) for potential securities fraud. This follows a report by Scorpion Capital raising concerns about Harmony's narcolepsy drug, Wakix.
November 15, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Harmony Biosciences is under investigation for potential securities fraud related to its narcolepsy drug, Wakix, following a critical report by Scorpion Capital.
The investigation by Levi & Korsinsky into Harmony Biosciences for potential securities fraud is significant, as it could lead to legal challenges and impact investor confidence. The concerns raised by Scorpion Capital about Wakix add to the potential negative sentiment, likely affecting HRMY's stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100